Enasidenib Mesylate and Insulin glargine
Determining the interaction of Enasidenib Mesylate and Insulin glargine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: enasidenib
Brand name: Idhifa, Idhifa
Synonyms: Enasidenib
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Enasidenib Mesylate-Insulin Glargine (U-100) Cartridge Systems and Pens
- Enasidenib Mesylate-Insulin Glargine (U-100) Vials
- Enasidenib Mesylate-Insulin Glargine (U-300) Pens
- Enasidenib Mesylate-Insulin glargine and lixisenatide
- Enasidenib Mesylate-Insulin glargine and lixisenatide Subcutaneous
- Enasidenib Mesylate-Insulin glargine, recombinant Subcutaneous
- Insulin glargine-EnBrace HR
- Insulin glargine-Enbrel
- Insulin glargine-Enbrel (Etanercept Prefilled Syringes)
- Insulin glargine-Enbrel (Etanercept Vials)
- Insulin glargine-Enbrel SureClick
- Insulin glargine-Encora